Showing results (691-700 of 702) with videos related to
Sort By:
Pageof 71
Biochemical and Biophysical Research Communications|July 9, 2023
The RNA polymerase II subunit B (RPB2) functions as a growth regulator in human glioblastomaXiao-Lu Li, Yi Xie, Yan-Ling Chen, et al.Journal of Experimental & Clinical Cancer Research : CR|July 16, 2022
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemiaFang Fang, Jun Lu, Xu Sang, et al.Zhonghua Yi Xue Za Zhi|September 14, 2013
[Telomere length and gene expression of shelterin in CD3(+) T cell of severe aplastic anemia patients]Ting Wang, Rong Fu, Hua-quan Wang, et al.Nature|January 4, 2023
Ultrathin quantum light source with van der Waals NbOCl<sub>2</sub> crystalQiangbing Guo, Xiao-Zhuo Qi, Lishu Zhang, et al.Cell Death & Disease|February 24, 2022
SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7Zi-Mu Zhang, Hai-Bo Cao, Zhi-Heng Li, et al.Acta Pharmacologica Sinica|June 23, 2026
Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathwayLong-Xiang Li, Bo-Yang Wei, Lei Jin, et al.Journal of Immunology Research|November 28, 2022
The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in NeuroblastomaSi-Qi Jia, Ran Zhuo, Zi-Mu Zhang, et al.Oncology Letters|October 29, 2021
MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1Yan-Ling Chen, Zi-Mu Zhang, Xiao-Lu Li, et al.Cell & Bioscience|March 19, 2022
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastomaYan-Ling Chen, Xiao-Lu Li, Gen Li, et al.Cancer Cell International|November 8, 2021
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1You Jiang, Shui-Yan Wu, Yan-Ling Chen, et al.Pageof 71